BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 31164292)

  • 1. [Eye and Behçet's disease].
    Ksiaa I; Abroug N; Kechida M; Zina S; Jelliti B; Khochtali S; Attia S; Khairallah M
    J Fr Ophtalmol; 2019 Jun; 42(6):626-641. PubMed ID: 31164292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eye and Behçet's disease.
    Ksiaa I; Abroug N; Kechida M; Zina S; Jelliti B; Khochtali S; Attia S; Khairallah M
    J Fr Ophtalmol; 2019 Apr; 42(4):e133-e146. PubMed ID: 30850197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ocular manifestations in Behçet's disease].
    Desbois AC; Terrada C; Cacoub P; Bodaghi B; Saadoun D
    Rev Med Interne; 2018 Sep; 39(9):738-745. PubMed ID: 29625716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ocular manifestations in Behçet's disease].
    Zeghidi H; Saadoun D; Bodaghi B
    Rev Med Interne; 2014 Feb; 35(2):97-102. PubMed ID: 24290834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ocular manifestations of Behçet's disease].
    Saadouli D; Lahmar A; Ben Mansour K; El Afrit N; Yahyaoui S; El Afrit MA
    J Fr Ophtalmol; 2021 Feb; 44(2):196-202. PubMed ID: 33380351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Uveitic glaucoma in Behçet's disease: When everything gets complicated].
    Belkhadir K; Boutimzine N; Tachfouti S; Laghmari M; Amazouzi A; Cherkaoui O
    J Fr Ophtalmol; 2020 Sep; 43(7):635-641. PubMed ID: 32622636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behçet's Uveitis: Current Diagnostic and Therapeutic Approach.
    Çakar Özdal P
    Turk J Ophthalmol; 2020 Jun; 50(3):169-182. PubMed ID: 32631005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The eye and Behçet's disease].
    Khairallah M; Ben Yahia S; Kahloun R; Khairallah-Ksiaa I; Messaoud R
    J Fr Ophtalmol; 2012 Dec; 35(10):826-37. PubMed ID: 23083770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behçet's disease.
    Bonfioli AA; Orefice F
    Semin Ophthalmol; 2005; 20(3):199-206. PubMed ID: 16282155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of TNF-alpha antagonist and other immunomodulators in the treatment of patients with ophthalmologic manifestations of Behcet's disease and HLA B51 positive vasculitis].
    Zlatanović G; Jovanović S; Veselinović D; Zivković M
    Vojnosanit Pregl; 2012 Feb; 69(2):168-74. PubMed ID: 22500372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern of uveitis in Behçet's disease in a referral center in Tunisia, North Africa.
    Khairallah M; Attia S; Yahia SB; Jenzeri S; Ghrissi R; Jelliti B; Zaouali S; Messaoud R
    Int Ophthalmol; 2009 Jun; 29(3):135-41. PubMed ID: 18365145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic factors of ocular involvement in Behçet's disease].
    Belkhadir K; Boutimzine N; Laghmari M; Amazouzi A; Tachfouti S; Cherkaoui O
    J Fr Ophtalmol; 2019 Jun; 42(6):612-617. PubMed ID: 31088739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Panuveitis with oral and genital ulcer misdiagnosed as Behcet's disease: two cases report and literature review].
    Wang Y; Yang L; Zhang ZL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 48(5):910-914. PubMed ID: 27752180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of Behçet's disease in the Indian population.
    Sachdev N; Kapali N; Singh R; Gupta V; Gupta A
    Int Ophthalmol; 2009 Dec; 29(6):495-501. PubMed ID: 18936879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and future treatments for Behçet's uveitis: road to remission.
    Mesquida M; Molins B; Llorenç V; Hernández MV; Espinosa G; Dick AD; Adán A
    Int Ophthalmol; 2014 Apr; 34(2):365-81. PubMed ID: 23729309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Uveitis in Behçet's Syndrome in Germany - Prognosis During Current Therapy].
    Stübiger N; Deuter C; Doycheva D
    Klin Monbl Augenheilkd; 2020 May; 237(5):591-598. PubMed ID: 32434242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis.
    Kötter I; Zierhut M; Eckstein AK; Vonthein R; Ness T; Günaydin I; Grimbacher B; Blaschke S; Meyer-Riemann W; Peter HH; Stübiger N
    Br J Ophthalmol; 2003 Apr; 87(4):423-31. PubMed ID: 12642304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ophthalmologic manifestations of Behçet's disease, about 33 cases].
    Andaloussi IB; Alami B; Abdellaoui M; Bhallil S; Bono W; Tahri H
    Pan Afr Med J; 2012; 13():83. PubMed ID: 23396991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular Manifestations and Visual Outcomes of Behçet's Uveitis in a Thai population.
    Pathanapitoon K; Kunavisarut P; Saravuttikul FA; Rothova A
    Ocul Immunol Inflamm; 2019; 27(1):2-6. PubMed ID: 29020486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behçet's syndrome: ocular features in an Australian population.
    Wakefield D; McCluskey P
    Aust N Z J Ophthalmol; 1990 May; 18(2):129-35. PubMed ID: 2390239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.